GalenusRx

GalenusRx has developed and commercialized the APPRAISE platform—a proprietary clinical decision support system that analyzes multi-drug, multi-gene, and drug-disease interactions to optimize medication safety. The platform delivers personalized risk assessments down to the DNA level using pharmacogenomics and real-world data. Peer-reviewed literature by its founders demonstrates improved outcomes from this approach. The company reports a return on investment of 3:1 or greater for value-based care clients. Their solutions are used by patients, providers, payers, health systems, pharmaceutical companies for biosimulation in clinical trials, and have been validated through patient testimonials.